NO20042389L - Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette - Google Patents
Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med detteInfo
- Publication number
- NO20042389L NO20042389L NO20042389A NO20042389A NO20042389L NO 20042389 L NO20042389 L NO 20042389L NO 20042389 A NO20042389 A NO 20042389A NO 20042389 A NO20042389 A NO 20042389A NO 20042389 L NO20042389 L NO 20042389L
- Authority
- NO
- Norway
- Prior art keywords
- awakening
- treating
- compound
- treatment
- providing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000019116 sleep disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0128674.9A GB0128674D0 (en) | 2001-11-30 | 2001-11-30 | Treatment of sleep disorders and the like |
| US10/305,354 US20030134878A1 (en) | 2001-11-30 | 2002-11-27 | Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| PCT/GB2002/005427 WO2003047580A1 (en) | 2001-11-30 | 2002-12-02 | Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042389L true NO20042389L (no) | 2004-06-08 |
Family
ID=9926729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042389A NO20042389L (no) | 2001-11-30 | 2004-06-08 | Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20030134878A1 (https=) |
| EP (1) | EP1455786A1 (https=) |
| JP (1) | JP2005515200A (https=) |
| CN (1) | CN1617723A (https=) |
| AU (2) | AU2002313364B2 (https=) |
| CA (1) | CA2468044A1 (https=) |
| GB (3) | GB0128674D0 (https=) |
| IL (1) | IL162146A0 (https=) |
| NO (1) | NO20042389L (https=) |
| PL (1) | PL370258A1 (https=) |
| RU (1) | RU2320340C2 (https=) |
| WO (1) | WO2003047580A1 (https=) |
| ZA (1) | ZA200404172B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0312425D0 (en) * | 2003-05-30 | 2003-07-09 | Boots Co Plc | Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
| EP1663247B1 (en) * | 2003-09-03 | 2009-10-28 | Novartis AG | Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain |
| WO2006041158A1 (ja) * | 2004-10-14 | 2006-04-20 | Daikin Industries, Ltd. | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
| JP2006137748A (ja) * | 2004-10-14 | 2006-06-01 | Daikin Ind Ltd | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
| US20070166336A1 (en) * | 2005-12-13 | 2007-07-19 | David Delmarre | Stable and palatable oral liquid sumatriptan compositions |
| US20070299127A1 (en) * | 2006-06-23 | 2007-12-27 | The Procter & Gamble Company | Compositions and kits comprising a melatonin component and an omega-3-fatty acid component |
| US20120071539A1 (en) * | 2006-12-12 | 2012-03-22 | Emory University | Compounds and methods for modulating the silencing of a polynucleotide of interest |
| EP2217279B1 (en) * | 2007-11-21 | 2017-11-01 | The Procter & Gamble Company | Preparations useful for treatment of cough |
| US20110065655A1 (en) * | 2009-09-17 | 2011-03-17 | Karry Whitten | Therapeutic composition to treat lesions caused by herpes simplex virus |
| US10420756B2 (en) | 2015-03-26 | 2019-09-24 | Sen-Jam Pharmaceutical Llc. | Methods and compositions to inhibit symptoms associated with veisalgia |
| GR1010679B (el) * | 2023-02-03 | 2024-04-26 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικη συνθεση παρακεταμολης υπο μορφη τροχισκων ή παστιλιων με βελτιωτικο γευσης συμβατο με την παρακεταμολη |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4269835A (en) * | 1979-12-13 | 1981-05-26 | Whittle Barry J | Nasal composition for relieving nasal distress |
| US4639459A (en) * | 1983-02-01 | 1987-01-27 | Burroughs Wellcome Co. | Use of trifluoromethyl compounds |
| US4642231A (en) * | 1983-07-20 | 1987-02-10 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines |
| US5025019A (en) * | 1984-04-09 | 1991-06-18 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| US6077822A (en) * | 1993-09-14 | 2000-06-20 | Dumex-Alpharma A/S | Drug salts |
| US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| WO2001012175A1 (en) * | 1999-08-13 | 2001-02-22 | Vela Pharmaceuticals Inc. | Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| NZ527832A (en) * | 2001-03-13 | 2006-03-31 | Penwest Pharmaceuticals Co | Chronotherapeutic dosage forms |
| US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
-
2001
- 2001-11-30 GB GBGB0128674.9A patent/GB0128674D0/en not_active Ceased
-
2002
- 2002-11-27 US US10/305,354 patent/US20030134878A1/en not_active Abandoned
- 2002-11-28 GB GBGB0227708.5A patent/GB0227708D0/en not_active Ceased
- 2002-12-02 CA CA002468044A patent/CA2468044A1/en not_active Abandoned
- 2002-12-02 US US10/496,643 patent/US20050282869A1/en not_active Abandoned
- 2002-12-02 GB GB0228045A patent/GB2383537B/en not_active Expired - Fee Related
- 2002-12-02 RU RU2004119832/15A patent/RU2320340C2/ru active
- 2002-12-02 WO PCT/GB2002/005427 patent/WO2003047580A1/en not_active Ceased
- 2002-12-02 AU AU2002313364A patent/AU2002313364B2/en not_active Ceased
- 2002-12-02 EP EP02785610A patent/EP1455786A1/en not_active Withdrawn
- 2002-12-02 IL IL16214602A patent/IL162146A0/xx unknown
- 2002-12-02 AU AU2002350897A patent/AU2002350897B2/en not_active Ceased
- 2002-12-02 PL PL02370258A patent/PL370258A1/xx not_active Application Discontinuation
- 2002-12-02 CN CNA028276256A patent/CN1617723A/zh active Pending
- 2002-12-02 JP JP2003548835A patent/JP2005515200A/ja active Pending
-
2003
- 2003-05-30 US US10/448,455 patent/US20040029927A1/en not_active Abandoned
-
2004
- 2004-05-27 ZA ZA200404172A patent/ZA200404172B/xx unknown
- 2004-06-08 NO NO20042389A patent/NO20042389L/no not_active Application Discontinuation
-
2005
- 2005-12-16 US US11/303,019 patent/US20070015800A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL370258A1 (en) | 2005-05-16 |
| RU2320340C2 (ru) | 2008-03-27 |
| CN1617723A (zh) | 2005-05-18 |
| US20070015800A1 (en) | 2007-01-18 |
| ZA200404172B (en) | 2005-09-01 |
| AU2002350897A1 (en) | 2003-06-17 |
| RU2004119832A (ru) | 2005-04-20 |
| AU2002313364B2 (en) | 2004-02-19 |
| JP2005515200A (ja) | 2005-05-26 |
| GB2383537A (en) | 2003-07-02 |
| GB2383537B (en) | 2003-12-10 |
| WO2003047580A1 (en) | 2003-06-12 |
| GB0227708D0 (en) | 2003-01-08 |
| US20040029927A1 (en) | 2004-02-12 |
| IL162146A0 (en) | 2005-11-20 |
| US20030134878A1 (en) | 2003-07-17 |
| CA2468044A1 (en) | 2003-06-12 |
| AU2002350897B2 (en) | 2008-12-11 |
| GB0128674D0 (en) | 2002-01-23 |
| EP1455786A1 (en) | 2004-09-15 |
| GB0228045D0 (en) | 2003-01-08 |
| US20050282869A1 (en) | 2005-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0312419D0 (en) | Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess | |
| EP1509279A4 (en) | DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES | |
| DE60116066D1 (de) | Titanium mit verminderter anfälligkeit für verfärbung in der atmosphäre und herstellungsverfahren dafür | |
| MXPA03007960A (es) | Compuestos y metodos para el tratamiento de desordenes urogenitales. | |
| AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
| NO20041588L (no) | Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser | |
| NO20035611D0 (no) | Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon | |
| NO20032636D0 (no) | 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| NO20042389L (no) | Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette | |
| EP1567198A4 (en) | MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES | |
| NO20034300L (no) | Nye cyano-substituerte dihydropyrimidinforbindelser og anvendelse for behandling av sykdommer | |
| AU5754701A (en) | Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders | |
| NO20052698D0 (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser. | |
| EP1648399A4 (en) | METHOD AND TOPIC COMPOSITION FOR TREATING SKIN HYPERPIGMENTATION | |
| AU2001251306A1 (en) | Treatment of sleep disorders with hypocretin-1 | |
| AU2002313364A1 (en) | Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith | |
| NO20052699D0 (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| DE50112505D1 (de) | Schäranlage und Schärverfahren | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| AU2003266965A1 (en) | Use of carboxamides for the treatment of tinnitus | |
| EP1539100A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS | |
| PL377520A1 (pl) | Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń | |
| GB0312425D0 (en) | Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith | |
| NO20022990D0 (no) | Fremgangsmåte og sammensetning for behandling av smerte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |